GeneDx
GeneDx Shares Fall on Short Seller Report
Several Wall Street analysts took issue with the short seller's report, calling the claims false and unrelated to GeneDx's current operations.
JP Morgan Healthcare Conference, Day 3: Grail, Ultima Genomics, Seer, GeneDx, Quanterix
Highlights from the third day included Quanterix's announcement of a new protein detection platform, to be launched later this year.
Preliminary Earnings Roundup: Natera, Guardant Health, Exact Sciences, CareDx, GeneDx, More
Several molecular diagnostics firms reported fourth quarter and full-year 2024 revenues and other business updates ahead of the annual JP Morgan Healthcare Conference this week.
Top Five Articles on GenomeWeb Last Week: Colorado Genetic Testing Lawsuit, Pleno Financing, More
Last week, GenomeWeb's readers were most interested in news about an ongoing lawsuit in Colorado claiming negligence against a hospital and GeneDx.
Parents are suing the defendants for negligent genetic counseling and testing that they allege precluded their ability to avoid having children with Duchenne.